关于先锋

Company Profile

R&d innovation


Anhui Pioneer Pharmaceutical Co., Ltd. was established in January 2004. Since the establishment of the company, it has attached great importance to project development. The company's R&D center covers an area of 1,000 square meters and has established a R&D management system. Anhui Pioneer Pharmaceutical Co., Ltd. has been rated as "National High-tech Enterprise", "Gazelle Enterprise" and "High-precision Special New Enterprise".

The company's R&D center has more than 30 full-time R&D personnel, including 3 doctors and 6 masters. The products developed mainly cover four major therapeutic areas: hypertension, hyperlipidemia, spirit, respiratory and digestion, and general health.

Since 2020, there are 7 clinical record varieties; 14 varieties have been declared; 4 drug approval documents have passed the consistency evaluation or deemed consistency evaluation, among which fenofibrate capsule (specification: 0.2g) is the first to pass the variety; There are more than 40 varieties under development, and the declarations mainly involve antibiotics, psychotropic drugs, general health drugs, and antiviral drugs.

Complying with national policies and promoting the development of the pharmaceutical industry, the company has developed into a technology-led production-oriented enterprise. The company has deployed the consistency evaluation work of all approval documents, which has come to an end. From 2023, the company will launch high-end generic drugs to lay a solid foundation for the future development of the company. Base.

Attached is a list of Anhui Pioneer's recent R&D projects

Serial number Project name Indication Classification Estimated time to market
1 Lamotrigine Dispersible Tablets Spiritual 2024
2 minoxidil liniment General health category 2024
3 Levofloxacin Injection Antibiotics 2024
4 Cefotaxime Sodium for Injection Antibiotics 2024
5 Cefuroxime Sodium for Injection Antibiotics 2024
6 Cefazolin Sodium for Injection Antibiotics 2024
7 Ceftriaxone Sodium for Injection Antibiotics 2024
8 Cefoxitin Sodium for Injection Antibiotics 2024
9 Sildenafil Citrate Orally Disintegrating Tablets General health category 2025
10 Orlistat Capsules General health category 2025
11 Lacosamide injection Spiritual 2025
12 Vardenafil Hydrochloride Tablets General health category 2025
13 Biapenem for Injection Antibiotics 2025
14 Ertapenem for injection Antibiotics 2025
15 Diltiazem hydrochloride for injection First Aid 2025
16 Glucosamine Sulfate Capsules General health category 2024

Copyright © 2023 Hypuron  Powered by:www.300.cn   SEO

Business License